Across the pharmaceutical industry there is a strong drive towards greater efficiency, from faster time to market, through to better manufacturing practice. Over the last decade, the regulatory environment has changed, as exemplified by the introduction of Quality by Design (QbD), but so too have the economics of the market place, with a buoyant generics sector intensifying the requirement for ...

This decline can be attributed primarily to a more cautious regulatory climate caused by recent highprofile safety issues. 3 As a result of the heightened bar to obtain FDA approval, the life sciences sector has been plagued by a dearth of new product flow. All players in the industry—even large pharmaceutical companies—have been affected. Notably, only Novartis and GlaxoSmithKline (GSK) releas...

The evidence suggests that information systems in most organisations are poorly integrated. We might therefore expect that inter-organisational e-commerce applications will only aggravate this situation. Here, we report on an Australian e-commerce project designed to improve pharmaceutical supply chain efficiency within the healthcare sector. One interesting outcome was that the standards that ...

The whole pharmaceutical area (pharmacy industry, pharmacy billing, clinical trials, pharmacovigilance, and drug-drug interaction detection) needed various innovative scientific solutions to solve the problems. A systematic review was performed on software applications widely used in including detection of drug interactions that assist healthcare professional. Our concluded computer has created...

The evidence suggests that information systems in most organisations are poorly integrated. We might therefore expect that inter-organisational e-commerce applications will only aggravate this situation. Here, we report on an Australian e-commerce project designed to improve pharmaceutical supply chain efficiency within the healthcare sector. One interesting outcome was that the standards that ...